Hypoglycemia (Locemia)

Hypoglycemia (Locemia) Overview

Status Acquired/​Merged
Latest Deal Type Asset Purch.

Hypoglycemia (Locemia) General Information

Description

A treatment for severe hypoglycemia in people with diabetes treated with insulin. The drug uses a proprietary glucagon nasal powder formulation that is delivered in an emergency situation using a single-use, ready-to-use device.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 8505 Chemin Dalton
  • Montreal, Quebec H4T CA
  • Canada
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hypoglycemia (Locemia) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Corporate Asset Purchase 09-Oct-2015 Completed

Hypoglycemia (Locemia) Former Investors (1)

To view Hypoglycemia (Locemia)‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Locemia Solutions Corporation Majority 000 0000 000000 0

Ready to get started?

Request a free trial